David Bailey
Stock Analyst at Morgan Stanley
(4.09)
# 1,753
Out of 4,683 analysts
216
Total ratings
52.6%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.50 | $2.32 | +50.86% | 5 | Aug 26, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $32.70 | $40.40 | -19.06% | 16 | Aug 25, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | n/a | $44.14 | - | 11 | Aug 24, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $23.90 | $15.67 | +52.52% | 16 | Aug 21, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Sell | $20.60 | $20.19 | +2.03% | 20 | Aug 21, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $123.00 | $135.93 | -9.51% | 16 | Aug 19, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $163.00 → $172.00 | $173.22 | -0.70% | 32 | Aug 19, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Hold | n/a | $32.54 | - | 30 | Aug 7, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Sell | $32.90 → $34.60 | $50.48 | -31.46% | 36 | Aug 4, 2026 | |
| RMD ResMed | Maintained: Hold | $230 | $235.69 | -2.41% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $127.50 → $152.50 | $182.78 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.50 → $1.35 | $0.44 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.05 → $3.55 | $6.07 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.46 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.36 | $3.14 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $1.06 | n/a | 1 | Jan 21, 2021 |
Integral Diagnostics Limited
Aug 26, 2026
Maintained: Buy
Price Target: $3.50
Current: $2.32
Upside: +50.86%
Ansell Limited
Aug 25, 2026
Maintained: Hold
Price Target: $32.70
Current: $40.40
Upside: -19.06%
Fisher & Paykel Healthcare Corporation Limited
Aug 24, 2026
Maintained: Buy
Price Target: n/a
Current: $44.14
Upside: -
Telix Pharmaceuticals Limited
Aug 21, 2026
Maintained: Buy
Price Target: $23.90
Current: $15.67
Upside: +52.52%
Sonic Healthcare Limited
Aug 21, 2026
Maintained: Sell
Price Target: $20.60
Current: $20.19
Upside: +2.03%
Cochlear Limited
Aug 19, 2026
Maintained: Hold
Price Target: $123.00
Current: $135.93
Upside: -9.51%
CSL Limited
Aug 19, 2026
Maintained: Buy
Price Target: $163.00 → $172.00
Current: $173.22
Upside: -0.70%
ResMed Inc.
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $32.54
Upside: -
Ramsay Health Care Limited
Aug 4, 2026
Maintained: Sell
Price Target: $32.90 → $34.60
Current: $50.48
Upside: -31.46%
ResMed
Jul 13, 2026
Maintained: Hold
Price Target: $230
Current: $235.69
Upside: -2.41%
Aug 15, 2024
Maintained: Buy
Price Target: $127.50 → $152.50
Current: $182.78
Upside: n/a
Feb 28, 2024
Maintained: Hold
Price Target: $1.50 → $1.35
Current: $0.44
Upside: n/a
Jan 31, 2024
Maintained: Buy
Price Target: $3.05 → $3.55
Current: $6.07
Upside: n/a
Aug 24, 2021
Maintained: Hold
Price Target: n/a
Current: $14.46
Upside: n/a
Jan 21, 2021
Maintained: Hold
Price Target: $0.36
Current: $3.14
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $1.06
Upside: n/a